Skip to Main Content
Yale Cancer Center
YSM Home

INFORMATION FOR

Diseases of the Digestive System - Small Intestines, Large Intestines & Rectum

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode (ECLIPSE)

What is the purpose of this trial?

The ECLIPSE (Evaluation of the ctDNA LUNAR test in an Average Patient Screening Episode) study is a prospective, observational multi-site study without randomization. The primary objective of the study is to evaluate the performance characteristics of a blood-based ctDNA LUNAR-2 test to detect colorectal cancer in a screen-relevant, average risk population.

  • Trial with
    Guardant Health, Inc.
  • Ages
    60 years - 84 years
  • Gender
    Both
Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Edgar Benitez

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

  • Last Updated
    07/23/2024
  • Study HIC
    #2000029086

Contact Information

For more information about this study, including how to volunteer, contact Edgar Benitez